SanBio is a pharmaceutical company that engages in the research and development of regenerative medicines for the treatment of neurological disorders... Read more
SanBio is a pharmaceutical company that engages in the research and development of regenerative medicines for the treatment of neurological disorders... Read more
News
Aug 01, 2022
MarketScreener
SanBio Co., Ltd.: SanBio : Notice regarding appointment of new corporate officers
Jun 15, 2022
MarketScreener
SanBio Co., Ltd.: SanBio : Recording of Non-operating Income (Foreign Exchange Gains), Deferred Income Taxes, and Short-Term Loans Payable
Jun 14, 2022
MarketScreener
SanBio Co., Ltd.: SanBio : Consolidated Financial Results for the Three Months Ended April 30, 2022
Apr 05, 2022
MarketScreener
SanBio Co., Ltd.: SB623 Demonstrated Sustained Improvement in Motor Impairment up to 48 Weeks and Associated with Improvement in Function and Activities of Daily Living in Patients with Chronic Traumatic Brain Injury
Mar 23, 2022
MarketScreener
SanBio Co., Ltd.: SanBio : DelayedRecording of Non-Operating Expenses (Financing Expenses)
Mar 11, 2022
MarketScreener
SanBio Co., Ltd.: SanBio : Announcement on Issuance Plans of Stock Options (Share Acquisition Rights)
Mar 11, 2022
MarketScreener
SanBio Co., Ltd.: SanBio : Partial Amendment to the Articles of Incorporation, Reduction in Amounts of Stated Capital and Capital Reserves and Appropriation of Capital Surplus
Mar 07, 2022
FirstWord Pharma
SanBio Co., Ltd.: SanBio: Notice Regarding Completion of Approval Filing for Japan SB623 Chronic TBI Program
Dec 16, 2021
MarketScreener
SanBio Co., Ltd.: SanBio : Consolidated Financial Results for the Nine Months Ended October 31, 2021
Dec 15, 2021
MarketScreener
SanBio Co., Ltd.: SanBio : Notice on the recording of other comprehensive income, non-operating income, and non-operating expenses
SanBio Co., Ltd. Competitors
1
2
3
4
5
6
7
8
9
10